Rheumatic Disease Clinics of North America

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	96
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	71
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	49
Contents	37
Copyright	29
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	28
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	26
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	21
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	21
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
Forthcoming Issues	19
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	17
COPA Syndrome from Diagnosis to Treatment	16
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	16
Copyright	15
Taxonomy of Quality of Care Indicators	14
Contributors	14
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	14
The Short and Long of COVID-19	12
Contents	12
Imaging Challenges and Developments in Large-vessel Vasculitis	12
Lessons Learned from the COVID-19 Pandemic in Rheumatology	12
Newer Immunosuppressants for Rheumatologic Disease	11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11

Vaccinations in Patients with Rheumatic Disease	11
It Takes Oysters to Generate Pearls	11
Primary Cardiac Involvement in Systemic Sclerosis	10
Copyright	10
Expanding the Treatment Team	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	9
Pulmonary Hypertension Associated with Connective Tissue Disease	9
De novo Connective Tissue Disorders as Immune-related Adverse Events	9
Rheumatology Pearls for the Primary Care Physician	8
Uveitis in Children and Adolescents	8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	8
Scleroderma: Best Approaches to Patient Care	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Chronic Nonbacterial Osteomyelitis	7
Preventative Care in Scleroderma	7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Guideline Development and Implementation in Rheumatic Disease	7
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	7
Cardiac MRI in Rheumatic Disease	7
COVID-19 and Rheumatology	7
Charles L Christian	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
A Guide to Contemporary Clinical Practice Guidelines	6
Imaging of the Major Salivary Glands in Rheumatic Disease	6
Heart Failure in Rheumatic Disease	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Contributors	6
E Carwile LeRoy, MD	6
Contents	6
The Challenges of New Biologic Therapies in Pediatrics	5
Forthcoming Issues	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
Copyright	5
Contributors	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
Beyond Coronary Artery Disease	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Management and Cure of Gouty Arthritis	4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Role of Environment in Pediatric Rheumatic Diseases	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4

Treatment Guidelines in Gout	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Copyright	4
CARRA	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Patient Engagement in Pediatric Rheumatology Research	4
Contents	4
The Role of Psychology in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Achieving Precision Medicine in Psoriatic Arthritis	3
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Interstitial Lung Disease	3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	3
Pediatric Rheumatology Comes of Age: Part I	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Forthcoming Issues	3
Technology to Assess and Treat Pain in Pediatric Rheumatology	3
Health Care Utilization	3
Imaging in Inflammatory Bowel Disease	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
The GRADE Method	3
Pediatric Rheumatology Comes of Age: Part II	2
COVID-19 in Pediatrics	2
Forthcoming Issues	2
Systemic Diseases and Heart Block	2
Preface	2
Nathan Zvaifler	2
Targeting Environmental Risks to Prevent Rheumatic Disease	2
Contents	2
Imaging in Juvenile Idiopathic Arthritis	2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases	2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	2
Contributors	2
Outcome Measures in Pediatric Rheumatic Disease	2
Precision Medicine	2
Contributors	2
Mental Health in Pediatric Rheumatology	2
Training the Next Generation of Rheumatologists	2
Forthcoming Issues	2
Forthcoming Issues	2
Perioperative Management of Rheumatic Disease and Therapies	2
J. Claude Bennett, MD	2
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	2
Long COVID for the Rheumatologist	1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	1
Highlights of Interdisciplinary Care in Rheumatology	1
Transitioning to Adulthood with a Rheumatic Disease	1
Contributors	1
Forthcoming Issues	1
Pediatric Rheumatology Comes of Age: Part I	1
Vasculitis	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
Rheumatic Complications of Immune Checkpoint Inhibitors	1
Targeted Treatment of Diseases of Immune Dysregulation	1
Foreword	1
Recent Updates in Juvenile Spondyloarthritis	1
Imaging in Rheumatology	1
Forthcoming Issues	1
Gerald P Rodnan	1
Axial Imaging in Spondyloarthritis	1
Foreword	1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	1
Forthcoming Issues	1
Treatment Guidelines in Vasculitis	1
Contributors	1
Juvenile Fibromyalgia	1
The Giants Of Rheumatology	1
The Promises and Perils of Social Media for Pediatric Rheumatology	1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
Imaging Revolutions in Modern Rheumatology	0
Coronavirus Disease-2019 in the Immunocompromised Host	0
Newer Immunosuppressants for Rheumatologic Disease	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
Emerging Concepts in Immune Dysregulation	0

Forthcoming Issues	0
Contributors	0
Type I Interferonopathies	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
Environmental Triggers for Vasculitis	0
Preventative Care in Scleroderma	0
Lessons from Carl M. Pearson 1919 – 1981	0
The Microbiome in Rheumatologic Diseases	0
Managing Cardiovascular Risk in Patients with Rheumatic Disease	0
The Future of Vasculitis	0
Contents	0
The Emerging Telehealth Landscape in Pediatric Rheumatology	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Forthcoming Issues	0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease	0
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	0
Contents	0
Environmental Risks for Systemic Sclerosis	0
Axial Psoriatic Arthritis	0
Contributors	0
Gastrointestinal Tract Considerations: Part II	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
Imaging in Rheumatology	0
Eric Bywaters and Barbara Ansell	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis	0
Vasculitis	0
Environmental Triggers for Rheumatic Diseases	0
Contributors	0
Microbiome and Rheumatic Diseases	0
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	0
Juvenile Localized Scleroderma	0
Guideline Development and Implementation in Rheumatic Disease	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
Central Nervous System Imaging in Rheumatic Diseases	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Copyright	0
Copyright	0
How the American College of Rheumatology Develops Guidelines	0
Immune Checkpoint Inhibitor-induced Sicca Syndrome	0
Forthcoming Issues	0
Central Nervous System Vasculitis	0
Edmund Lawrence Dubois (1923–1985)	0
Lessons on Telemedicine in Rheumatology	0
Mental Health Considerations in Chronic Disease	0
Naomi Rothfield, MD, MACR	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Gut and Joint Microbiomes	0
Copyright	0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	0
Vasculitis and Pregnancy	0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease	0
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Immunotherapy Toxicity Management in Clinical Practice	0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights	0
Copyright	0
Systemic Lupus Erythematosus Risk	0
Rheumatology Pearls for the Primary Care Physician	0
Forthcoming Issues	0
Rheumatoid Arthritis	0
Environmental Risks for Inflammatory Myopathies	0
Disparities in Pediatric Rheumatic Diseases	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
Systemic Autoinflammatory Diseases	0
Scleroderma Skin	0
Highlights of Interdisciplinary Care in Rheumatology	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
Pediatric Rheumatology Comes of Age: Part II	0
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders	0
Environmental Risks for Spondyloarthropathies	0
Environmental Triggers of Hyperuricemia and Gout	0
Pediatric Rheumatology Comes of Age: Part I	0
Psoriatic Arthritis Updates	0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
New Developments in Imaging in Crystalline Arthritis	0
New and Emerging Rheumatic Diseases	0
Environmental Triggers for Rheumatic Diseases	0
Contents	0
Juvenile Idiopathic Arthritis Treatment Updates	0
Scleroderma: Best Approaches to Patient Care	0
Rheumatic Immune-related Adverse Events	0
Forthcoming Issues	0
Foreword	0
Emerging Concepts in Immune Dysregulation	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0
Isolated Aortitis	0
Vasculitis Mimics and Other Related Conditions	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Forthcoming Issues	0
Contents	0
Contributors	0